000 | 01849 a2200505 4500 | ||
---|---|---|---|
005 | 20250513171359.0 | ||
264 | 0 | _c19990520 | |
008 | 199905s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.510290419 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaylor, B S | |
245 | 0 | 0 |
_aThe role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cApr 1999 |
||
300 |
_a1199-207 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytokines _xpharmacology |
650 | 0 | 4 |
_aDNA _xmetabolism |
650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aI-kappa B Proteins |
650 | 0 | 4 |
_aLiver _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 |
_aOkadaic Acid _xpharmacology |
650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aLiu, S | |
700 | 1 | _aVillavicencio, R T | |
700 | 1 | _aGanster, R W | |
700 | 1 | _aGeller, D A | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 29 _gno. 4 _gp. 1199-207 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.510290419 _zAvailable from publisher's website |
999 |
_c10054652 _d10054652 |